PerspectiveBi-specific Therapeutics

Engineered Proteins Pull Double Duty

Science Translational Medicine  03 Feb 2010:
Vol. 2, Issue 17, pp. 17ps5
DOI: 10.1126/scitranslmed.3000276

You are currently viewing the abstract.

View Full Text

Abstract

Myriad bi-specific proteins have been developed that recognize two different clinical targets, with the goal of achieving enhanced therapeutic effects as compared with proteins that interact with only one target. These engineered proteins are starting to enter clinical testing for a variety of biomedical applications, particularly cancer treatment.

Footnotes

  • Citation: J. R. Cochran, Engineered proteins pull double duty. Sci. Transl. Med. 2, 17ps5 (2010).

View Full Text